TP53 and cancer: Importantly, MDM4 has proven to be oncogenic not only in the context of wt p53, but recent work from our group (Miranda et al., 2017) and the Lozano lab (Xiong et al., 2017) also demonstrated that MDM4 promotes cancers in a mutant p53 context, contrary to the prevailing dogma.